- Home
- NISN vs ANVS Comparison
NISN vs ANVS Comparison
Compare NISN & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NISN
- ANVS
- Stock Information
- Founded
- NISN 2005
- ANVS 2008
- Country
- NISN China
- ANVS United States
- Employees
- NISN N/A
- ANVS N/A
- Industry
- NISN Metal Fabrications
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- NISN Industrials
- ANVS Health Care
- Exchange
- NISN Nasdaq
- ANVS Nasdaq
- Market Cap
- NISN 23.5M
- ANVS 24.2M
- IPO Year
- NISN 2016
- ANVS 2020
- Fundamental
- Price
- NISN $3.96
- ANVS $2.64
- Analyst Decision
- NISN
- ANVS Strong Buy
- Analyst Count
- NISN 0
- ANVS 5
- Target Price
- NISN N/A
- ANVS $34.75
- AVG Volume (30 Days)
- NISN 62.2K
- ANVS 412.3K
- Earning Date
- NISN 04-29-2025
- ANVS 05-13-2025
- Dividend Yield
- NISN N/A
- ANVS N/A
- EPS Growth
- NISN N/A
- ANVS N/A
- EPS
- NISN 1.43
- ANVS N/A
- Revenue
- NISN $340,219,546.00
- ANVS N/A
- Revenue This Year
- NISN N/A
- ANVS N/A
- Revenue Next Year
- NISN N/A
- ANVS N/A
- P/E Ratio
- NISN $18.96
- ANVS N/A
- Revenue Growth
- NISN 8.05
- ANVS N/A
- 52 Week Low
- NISN $3.14
- ANVS $1.11
- 52 Week High
- NISN $22.55
- ANVS $17.88
- Technical
- Relative Strength Index (RSI)
- NISN 37.20
- ANVS 74.50
- Support Level
- NISN $4.38
- ANVS $1.95
- Resistance Level
- NISN $4.84
- ANVS $2.58
- Average True Range (ATR)
- NISN 0.54
- ANVS 0.24
- MACD
- NISN -0.02
- ANVS 0.07
- Stochastic Oscillator
- NISN 3.91
- ANVS 100.00
About NISN NiSun International Enterprise Development Group Co. Ltd.
NiSun International Enterprise Development Group Co Ltd is a provider of supply chain solutions and integrated financial services. Nisun is dedicated to providing professional supply chain solutions to Chinese and foreign enterprises and financial institutions. Through its subsidiaries, it is engaged in delivering supply chain solutions, and supply chain trading services to its customers across different industries. The company also provides financial solutions to small and mid-sized enterprises within the supply chain ecosystem. Using its fintech platforms, it provides various financing options, including supply chain financing, trade financing, and receivables financing. Geographically, its operations are predominantly focused on markets within the People's Republic of China.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.